Skip to main content
Clinical Trials/NCT05453877
NCT05453877
Recruiting
N/A

Clinical Indicators and Brain Image Data: a Cohort Study Based on Kailuan Cohort

Beijing Friendship Hospital2 sites in 1 country1,000 target enrollmentAugust 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Brain Diseases
Sponsor
Beijing Friendship Hospital
Enrollment
1000
Locations
2
Primary Endpoint
White matter hyperintensity of the brain measured by MRI (magnetic resonance imaging)
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The investigators will analyze the relationship between the medical history, physiological indicators and the cerebral small vessel disease as well as the structural and functional changes of the brain/head and neck organs in a large sample size of subjects (participants), to identify the influencing factors of the occurrence and development of cerebral small vessel disease as well as the structural and functional changes of the brain/head and neck organs, so as to provide objective clues for early intervention of the disease and improve clinical outcomes.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
August 1, 2030
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Wang, Zhenchang

Professor

Beijing Friendship Hospital

Eligibility Criteria

Inclusion Criteria

  • Age from 18 to 90 years old;
  • Comes from the Kailuan Cohort, completed ≥1 visits which the medical history, physiological indicators were measured;
  • Without contraindications of CT and MR scan;
  • Can cooperate with the measurement of the medical history, physiological indicators and brain imaging.

Exclusion Criteria

  • Known clinical history with congenital or acquired organic diseases (such as aortic stenosis);
  • Known history of drug abuse;
  • Pregnant and lactating women;
  • With clinical history of psychiatric diseases (such as schizophrenia).

Outcomes

Primary Outcomes

White matter hyperintensity of the brain measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

microbleeds of the brain measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

White matter microstructural integrity of the brain measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

Cerebral blood flow measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

Brain volume measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

Lacunes of the brain measured by MRI (magnetic resonance imaging)

Time Frame: every two years up to 30 years

Secondary Outcomes

  • Blood pressure (both Systolic and Diastolic Blood Pressure)(every two years up to 30 years)
  • BMI (body mass index)(every two years up to 30 years)
  • blood glucose level(every two years up to 30 years)
  • Cervical vascular ultrasound(every two years up to 30 years)
  • Fundus optical coherence tomography (OCT)(every two years up to 30 years)
  • Fundus color photography of the eyes(every two years up to 30 years)
  • Uric acid(every two years up to 30 years)

Study Sites (2)

Loading locations...

Similar Trials